SESSION TITLE: Other Infections SESSION TYPE: Affiliate Case Report Poster PRESENTED ON: Tuesday, October 31, 2017 at 01:30 PM - 02:30 PM INTRODUCTION: The reversed halo sign (RHS) has been described with increasing incidence in pulmonary mucormycosis in immunocompromised hosts, which has a high risk of morbidity and mortality.1 CASE PRESENTATION: A 58-year-old woman with acute lymphoblastic leukaemia who had completed her first cycle of hyper-CVAD chemotherapy presented with persistent fever for 3 days and neutropenia. She was empirically started on piperacillin-tazobactam for neutropenic sepsis. Chest CT scan showed a left upper lobe lesion with central ground-glass density surrounded by denser consolidation, corresponding to the RHS (Fig.1). It involved the mediastinum and abutted the pericardium and main pulmonary trunk. She underwent a bronchoscopy with BAL and transbronchial lung biopsy for which microbiology and histology were unremarkable. Post-bronchoscopy, she was started on ambisome and had a brain MRI which was normal. However, she continued to be febrile. She underwent a left VATS which was converted to a posterolateral thoracotomy with upper lobectomy and abscess resection. Intraoperatively, there was abscess invasion into the anterior chest wall, pericardium and right ventricular outlet tract. Histology showed a cavitatory nodule surrounded by geographic necrosis with mucormycosis and fungal angioinvasion (Fig 2). She completed 2 months of ambisome before conversion to posaconazole. Post-operative recovery was uneventful and she underwent her second cycle of chemotherapy on post-operative day 24 with further plans for haematopoetic stem cell transplant following completion of chemotherapy. DISCUSSION: The RHS may be seen on chest CT in a range of conditions. It was originally described in cryptogenic organising pneumonia;2 but can be seen in invasive pulmonary infections, Pneumocystis jirovecii pneumonia, sarcoidosis, lipoid pneumonia, lymphomatoid granulomatosis, granulomatosis with polyangiitis and lepidic predominant lung adenocarcinoma.2,3 It has been described with an increasing incidence in pulmonary mucormycosis, particularly in immunocompromised patients with haematologic disease. Pulmonary mucormycosis has high morbidity and mortality. Early diagnosis and prompt treatment with amphotericin B and surgical resection can improve outcomes.1 CONCLUSIONS: The RHS in an immunocompromised host should prompt consideration of invasive fungal infections, including pulmonary mucormycosis. Reference #1: Legouge C, Caillot D, Chrétien ML, et al. The reversed halo sign: Pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia? Clin Infect Dis. 2014;58(5):672-8. Reference #2: Raju S, Ghosh S, Mehta AC. Chest Computed Tomography Signs in Pulmonary Disease - A Pictorial Review. CHEST Pulm Dis - A Pict Rev CHEST [Internet]. 2016;12. http://dx.doi.org/10.1016/j.chest.2016.12.033 Reference #3: Marchiori E, Zanetti G, Meirelles GS, et al. The reversed halo sign on high-resolution CT in infectious and noninfectious pulmonary diseases. Am J Roentgenol. 2011 Jul;197(1):W69-75 DISCLOSURE: The following authors have nothing to disclose: Michelle Kam, Lionel Cheng, Norman Chan, Denise Tan, Heng Joo Ng, Keng Leong Tan No Product/Research Disclosure Information
Read full abstract